IMP-361

N/A

Report date: 2022/08/26 10:54:22

Base Information

Drug NameIMP-361
Drug Alias NameIMP-361
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionLymphocyte activation gene 3 protein inhibitorsProtein E7 modulators
TargetsLymphocyte activation gene 3 proteinProtein E7
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmutep
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmutep
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A